Millets occupy a unique intersection of nutrition and pharmaceutical benefit, earning the label of 'nutraceuticals.' Their bioactive compounds exert targeted effects on biochemical pathways, offering therapeutic value beyond basic nutrition. According to a 2024 Frontiers in Nutrition review (Jacob et al., 2024), millets demonstrate multi-dimensional nutrigenomic activity.
Core nutraceutical properties of millets:
Hypoglycaemic (anti-diabetic): Polyphenols inhibit α-amylase and α-glucosidase enzymes; fiber reduces postprandial glucose surge.
Anti-tumorigenic: Bioactive peptides and dietary fiber promote apoptosis and inhibit cancer cell proliferation.
Anti-atherosclerogenic: Dietary fiber and phytosterols reduce LDL cholesterol deposition in arterial walls.
Antioxidant: Tannins, phytates, phenols, flavonoids, and carotenoids neutralize reactive oxygen species (ROS) and reduce oxidative stress.
Anti-hypertensive: Peptides and potassium support vascular relaxation and blood pressure reduction.
Anti-inflammatory: Quercetin, curcumin-like compounds, and ferulic acid suppress pro-inflammatory cytokines.
Antimicrobial: Certain phenolic compounds inhibit pathogenic bacteria and fungi, supporting gut microbiome balance.
Immunomodulatory: Iron, zinc, and selenium in millets support immune cell function and host defense mechanisms.
© 2023 - 2026 Millets News. All rights reserved.